AMGN: CHMP Finds Study Breach
AMGN's Advocate study was conducted in breach of good clinical practice principles with incorrect and misleading data
AMGN CHMP has concluded that the Advocate study was conducted in breach of good clinical practice principles.
The study data provided at the time of the assessment of the marketing authorisation application were found to be incorrect and misleading